HRT Financial’s Neurotrope, Inc. Common NTRP Stock Holding History

HRT Financial’s Portfolio NTRP Stock Details NTRP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,660	Closed	-$10K	–	1556
2019 Q4	$10K	Buy	+10,660	New	+$8.31K	﹤0.01%	1095

Other funds holding NTRP

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFAS

Acorn Financial Advisory Services Reston, Virginia $753M AUM 36.94% 1-Year Est. Return

PTP

Platform Technology Partners New York $519M AUM 20% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OGC

One68 Global Capital New York $30.9M AUM

HRT Financial's NTRP Position: Q1 2020 in Review

HRT Financial sold out of Neurotrope, Inc. Common (NTRP) in Q1 2020, closing a stake of 10,660 shares — an estimated $10K sold.

HRT Financial first reported a position in NTRP in Q4 2019 and held it in 1 quarter. The position peaked at $10K in Q4 2019. 28 funds tracked by Wall St. Rank hold NTRP as of Q1 2020.

HRT Financial reported no remaining Neurotrope, Inc. Common position as of Q1 2020 after selling out during the quarter.
HRT Financial sold 10,660 Neurotrope, Inc. Common shares in Q1 2020, an estimated $10K.
HRT Financial first reported a position in Neurotrope, Inc. Common in Q4 2019 and held it in 1 quarter.
HRT Financial's Neurotrope, Inc. Common position peaked at $10K in Q4 2019.
28 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q1 2020.

Based on HRT Financial's 13F filing for Q1 2020, filed 15 May 2020.